Maternal-Fetal Medicine Billing 2026: Carving High-Risk Consultations and Ultrasounds Out of the Global OB Package

By Rcmaxis Revenue Cycle Team  ·  September 2026  ·  12 min read

The global maternity package is built around the assumption of a routine, low-risk pregnancy — a bundled payment covering antepartum visits, delivery, and postpartum care under one code, on the theory that most pregnancies don't generate enough separately billable complexity to justify itemized billing. High-risk pregnancy care breaks that assumption completely, and maternal-fetal medicine practices that bill as though the global package still applies are quietly absorbing thousands of dollars in legitimately separate, medically necessary services per patient.

This guide covers what actually carves out of the global OB package for high-risk care, the ultrasound code selection that determines whether a scan pays as a basic or detailed study, and the documentation that has to support each carved-out service as medically necessary rather than routine.

What Actually Carves Out of the Global Package

The global maternity package assumes routine antepartum care. Services related to a high-risk condition — not the routine pregnancy itself — are separately billable when the referring relationship and the medical necessity are both clearly documented.

The billing failure isn't usually a misunderstanding that these services exist — it's a workflow default where the MFM practice's own claims get bundled into the referring OB's global code out of habit, because the coding staff is used to a single global claim per pregnancy and doesn't have a clean process for flagging which specific visits belong to the high-risk carve-out instead.

76805 vs. 76811: The Ultrasound Code That Determines the Payment

CPT 76805 (standard anatomic ultrasound) and 76811 (detailed fetal anatomic ultrasound) aren't interchangeable based on which one pays more — they describe genuinely different levels of examination, and billing 76811 without the documentation to support the additional anatomic detail it requires is one of the most common findings in payer audits of MFM ultrasound billing.

The practical safeguard is making sure the sonographer's worksheet and the interpreting physician's report both reflect the specific additional anatomic detail 76811 requires — not just a checkbox indicating "detailed" was selected in the ultrasound system's reporting template, which by itself doesn't constitute the clinical documentation a payer audit will look for.

Modifier 25 and 59 on the Same Visit Day

High-risk OB visits often stack a consultation, an ultrasound, and antepartum testing on the same day — which means getting the modifier usage right on same-day, same-provider claims is a recurring point of denial.

Payers that see modifier 25 or 59 used on a high percentage of a practice's claims — a pattern common in MFM given how often multiple services stack on one visit — sometimes flag the practice for targeted review purely on the modifier-usage rate, independent of whether any individual claim is actually wrong. Clean, specific documentation for each modifier use is the practice's protection when that kind of aggregate review happens.

OIG and Payer Audit Focus: Ultrasound Frequency and Medical Necessity

High-risk pregnancy monitoring legitimately requires more frequent ultrasounds and antepartum testing than routine care — but that same clinical reality creates an audit target, because ultrasound frequency is one of the more visible, quantifiable patterns a payer's claims-analytics system can flag without even opening a chart.

The documentation fix isn't reducing genuinely necessary monitoring frequency — that's a clinical decision, not a billing one — it's making sure each additional ultrasound or antepartum test in a series has its own stated indication in the referring note or the MFM consultation record, distinct from "routine high-risk follow-up," which by itself doesn't establish medical necessity for a specific additional study on a specific date.

Prior Authorization: What Payers Actually Require

Prior authorization requirements for MFM services vary by payer, but the pattern that trips up practices most often is treating the initial consultation authorization as covering everything that follows, when payers frequently require separate authorization for the ongoing surveillance testing that follows an initial high-risk determination.

Tracking authorization expiration dates against the actual testing schedule — not against the pregnancy's expected due date in general — is what prevents a mid-third-trimester surveillance ultrasound from denying because the authorization window technically closed two visits earlier.

Common Maternal-Fetal Medicine Denial Patterns

• MFM services bundled into the referring OB's global maternity claim by habit: Fixed by building a workflow that flags high-risk carve-out visits as separately billable from intake.
• 76811 billed without documentation of the specific additional anatomic detail it requires: Fixed by confirming the sonographer worksheet and interpretation both reflect true detailed-study criteria.
• Repeat ultrasounds billed without a distinct stated indication for each study: Fixed by documenting the specific new finding or risk factor prompting each additional scan.
• Authorization for ongoing surveillance testing allowed to lapse mid-pregnancy: Fixed by tracking authorization windows against the actual testing schedule, not the due date.

Maternal-fetal medicine billing works against a global maternity structure that was never designed for the volume and complexity of genuinely high-risk care, and the practices that recover the revenue they're actually owed are the ones that treat every high-risk visit as a deliberate carve-out decision — documented, coded, and authorized on its own terms — rather than something that happens to ride along inside someone else's global claim. The clinical case for more frequent monitoring in a high-risk pregnancy is usually straightforward. Making sure the billing reflects that same case, visit by visit, is the part that determines whether the practice actually gets paid for the care it's providing.